Improving Veteran Referral to Cardiac Rehabilitation
Official title: Improving Veteran Referral to Cardiac Rehabilitation: A Hybrid Effectiveness-Implementation Trial
Run by VA Office of Research and Development · NCT07079358 · Data updated 2026-11-12
This project tests whether a Veteran Cardiac Rehabilitation Referral Program helps more eligible veterans get referrals and start cardiac rehabilitation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 816 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 3 sites (Gainesville, Florida and 2 other locations) |
| Status | Recruiting |
| Started | February 23, 2026 |
| Main results expected | July 1, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | October 1, 2026 |
| Trial ID | NCT07079358 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Veterans hospitalized with acute myocardial infarction, PCI, cardiac valve surgery, CABG, or systolic heart failure at the three participating VA centers.
✕Probably not a fit
Veterans not eligible for or not referred to cardiac rehabilitation, or those with post-hoc exclusions such as immediate death or discharge to facilities, may derive no benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-arm, pre-post study at three VA medical centers enrolling 816 eligible veterans to see if the VCR2P referral program increases CR referrals and initiation over 12 months. The study uses a before-and-after comparison (6 months before vs 6 months after program implementation) to assess impact in real-world VA settings. In addition to referral and initiation rates, the study collects qualitative feedback from physicians, nurses, and veterans to identify factors that support or hinder implementation and guide broader adoption if successful. A type 2 hybrid design combines effectiveness and implementation outcomes to inform scalability and sustainability across the VA.
Why it matters
Potential benefit: If successful, the program could raise referral and participation in cardiac rehabilitation among Veterans and inform scalable implementation across VA facilities.
How similar studies have gone: Previous implementation studies in real-world settings have shown that structured referral programs can improve uptake of rehabilitation services, supporting the potential for VCR2P.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All Veterans hospitalized with acute myocardial infarction, percutaneous coronary intervention, cardiac valve surgery, coronary artery bypass grafting, or systolic heart failure at the three participating VA medical centers (Nashville, Dallas, and Gainesville). Exclusion Criteria: * No exclusion criteria during the intervention period * however, post-hoc analysis will exclude Veterans with documented reasons preventing CR attendance including death during hospitalization or within 30 days of discharge, discharge to inpatient rehabilitation or skilled nursing facilities, significant cognitive impairment, high-risk ventricular arrhythmias, or explicit refusal of cardiac rehabilitation (CR) services.
Where it's running
-
North Florida/South Georgia Veterans Health System, Gainesville, FL
Gainesville, Florida, United States Recruiting -
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
Nashville, Tennessee, United States Recruiting -
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX
Dallas, Texas, United States Recruiting
Study contacts
- Principal investigator: Justin M Bachmann, MD MPH — Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
- Study coordinator: Justin M Bachmann, MD MPH
- Email: justin.bachmann2@va.gov
- Phone: (615) 327-4751
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
Petrelintide for weight loss in people with overweight/obesity and heart disease
This study tests whether petrelintide helps people with overweight or obesity and cardiovascular disease lose weight when added to a reduced-calorie diet and more physical activity, compared with a placebo.
-
VERVE-102 for adults with or at high risk for heart disease
This study tests whether VERVE-102 can lower bad cholesterol (LDL-C) compared with a placebo in adults with plaque buildup or high risk for it.
-
Clazakizumab for adults with high hsCRP at risk for a heart event
This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.